Answers are grounded in this paper and cite their sources.
Metformin is first or second choice for oral treatment of type 2 diabetes and is licensed for its prevention. Numerous articles propagate metformin as a drug that combats diseases and lowers the risks that are associated with advanced chronological age, such as cancer, diabetes, frailty, coronary heart disease and, most recently, even COVID-19. However, no clinical studies yet exist which prove that metformin delays the onset of such age-related diseases in elderly healthy individuals. Metformin – contrary to expectations – interferes with the beneficial effects of endurance or resistance training, is suspected to rapidly lead to mild anaemia and proven to cause vitamin B12 deficiency.
No takes yet. Share an insight, caveat, or question.
Glossmann et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: